All Phenotypes Myl1<tm1(cre)Sjb> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Myl1^tm1(cre)Sjb
targeted mutation 1, Steven J Burden
MGI:1931135

Summary

12 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Atad3a^{tm1c(KOMP)Wtsi}/Atad3a^{tm1c(KOMP)Wtsi} Myl1^tm1(cre)Sjb/Myl1⁺	B6J.Cg-Myl1^tm1(cre)Sjb Atad3a^{tm1c(KOMP)Wtsi}	MGI:6197947
cn2	Hprt1^{tm1(CAG-Gys1*)Jjg}/? Myl1^tm1(cre)Sjb/Myl1⁺	involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ	MGI:6273838
cn3	Myl1^tm1(cre)Sjb/0 Ndufab1^tm1Xiwa/Ndufab1^tm1Xiwa	involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6	MGI:6476948
cn4	Myl1^tm1(cre)Sjb/Myl1⁺ Shc1^tm4Paw/Shc1^tm9Paw	involves: 129S1/Sv * 129X1/SvJ	MGI:3717105
cn5	Myl1^tm1(cre)Sjb/Myl1⁺ Shc1^tm7Paw/Shc1^tm9Paw	involves: 129S1/Sv * 129X1/SvJ	MGI:3717106
cn6	Myl1^tm1(cre)Sjb/Myl1⁺ Shc1^tm3Paw/Shc1^tm9Paw	involves: 129S1/Sv * 129X1/SvJ	MGI:3717104
cn7	Myl1^tm1(cre)Sjb/Myl1⁺ Shc1^tm9Paw/Shc1^tm9Paw	involves: 129S1/Sv * 129X1/SvJ	MGI:3717102
cn8	Myl1^tm1(cre)Sjb/Myl1⁺ Tfam^tm1Lrsn/Tfam^tm1Lrsn	involves: 129S1/Sv * 129X1/SvJ * C57BL/6	MGI:2450161
cn9	Trp53inp2^tm1Azo/Trp53inp2^tm1Azo Myl1^tm1(cre)Sjb/Myl1⁺	involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	MGI:6279199
cn10	Myl1^tm1(cre)Sjb/Myl1⁺ Smarcd3^tm1Jddl/Smarcd3^tm1Jddl	involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	MGI:6367830
cn11	Ralgapa1^{tm2c(KOMP)Wtsi}/Ralgapa1^{tm2c(KOMP)Wtsi} Myl1^tm1(cre)Sjb/Myl1⁺	involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N	MGI:6456689
cn12	Cox10^tm1Ctm/Cox10^tm1Ctm Myl1^tm1(cre)Sjb/Myl1⁺	involves: 129X1/SvJ * C57BL/6	MGI:3609951

Allelic Composition	Atad3a^{tm1c(KOMP)Wtsi}/Atad3a^{tm1c(KOMP)Wtsi} Myl1^tm1(cre)Sjb/Myl1⁺
Genetic Background	B6J.Cg-Myl1^tm1(cre)Sjb Atad3a^{tm1c(KOMP)Wtsi}

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Atad3a^{tm1c(KOMP)Wtsi} mutation (0 available); any Atad3a mutation (30 available)
Myl1^tm1(cre)Sjb mutation (2 available); any Myl1 mutation (17 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cellular

abnormal mitochondrial crista morphology ( J:263681 )

• mostly oriented parallel to outer membrane, sometimes forming concentric circles in tibialis anterior muscle fibers at age 2 and 5 months

• reduced cristae surface per mitochondrion in tibialis anterior muscle fibers at age 2 months

• lamellar structure in tibialis anterior muscle fibers at age 2 months

• loss of lamellar structure with predominant circular structures in tibialis anterior muscle fibers at age 5 months

disorganized mitochondrial cristae ( J:263681 )

• 60% reduction in number of cristae junctions (contact with outer membrane) in tibialis anterior muscle fibers at age 2 months

• mostly oriented parallel to outer membrane, sometimes forming concentric circles in tibialis anterior muscle fibers at ages 2 and 5 months

abnormal muscle fiber mitochondrial morphology ( J:263681 )

• clear matrix areas, electron-dense inclusions, fragmentation and degeneration in tibialis anterior muscle fibers at age 5 months

• drastically reduced mitochondrial mass in focal areas of skeletal muscle fibers

• increased subsarcolemmal mitochondrial proliferation in some muscle fibers

decreased skeletal muscle fiber mitochondrial DNA content ( J:263681 )

• 30% reduction at age 5-6 months, 55% at 12 months and 45% at 18 months in skeletal muscle

• high level of age-related deletions in skeletal muscle at ages 12 months and 18 months

• high level of age-related rearrangements in skeletal muscle at age 20 months

decreased mitochondrial size ( J:263681 )

• in tibialis anterior muscle fibers at age 5 months

abnormal oxidative phosphorylation ( J:263681 )

• 50% reduction in steady-state levels of complex I (Ndufb8) and complex V (Atp5a1) markers in skeletal muscle from age 3 months

• reduction in levels of complex IV marker mt-Co1 in skeletal muscle from age 5 months

• steady-state levels of complex II (Sdha) and complex III (Uqcrc1) markers in skeletal muscle

muscle

abnormal muscle fiber morphology ( J:263681 )

• significantly lower cross-sectional area at age 5 months

• pale cores lacking cytochrome c oxidase and succinate dehydrogenase activity (suggesting lack of mitochondria); small single cores at age 5 months, larger and/or multiple cores at age 18 months

• increased subsarcolemmal cytochrome c oxidase and succinate dehydrogenase activity (suggesting increased number of mitochondria) in some fibers

abnormal muscle fiber mitochondrial morphology ( J:263681 )

• clear matrix areas, electron-dense inclusions, fragmentation and degeneration in tibialis anterior muscle fibers at age 5 months

• drastically reduced mitochondrial mass in focal areas of skeletal muscle fibers

• increased subsarcolemmal mitochondrial proliferation in some muscle fibers

decreased skeletal muscle fiber mitochondrial DNA content ( J:263681 )

• 30% reduction at age 5-6 months, 55% at 12 months and 45% at 18 months in skeletal muscle

• high level of age-related deletions in skeletal muscle at ages 12 months and 18 months

• high level of age-related rearrangements in skeletal muscle at age 20 months

skeletal muscle fiber atrophy ( J:263681 )

• increased empty spaces between fibers at age 18 months

skeletal muscle fiber degeneration ( J:263681 )

• at age 18 months

decreased skeletal muscle weight ( J:263681 , J:263681 )

	• reduced quadriceps, gastrocnemius and tibialis anterior muscle weight as percentage of body weight from age 5 months (J:263681)
	• gastrocnemius and tibialis anterior at age 18 months (J:263681)

behavior/neurological

abnormal motor coordination/balance ( J:263681 )

• stay on a progressively accelerating cylinder for shorter time in rotarod test

decreased grip strength ( J:263681 )

• reduced maximum grip strength in forelimbs at age 6 months with no further worsening

weakness ( J:263681 )

• activity on treadmill at age 2 months

• increase in falling frequency on treadmill from age 3 months

decreased locomotor activity ( J:263681 )

• decreased travelling distance, ambulatory counts and increased resting time in open field test from age 6 months

homeostasis/metabolism

abnormal cholesterol homeostasis ( J:263681 )

• lipid composition in skeletal muscle at age 2 months

• decreased levels of cholesterol esters (CEs) synthesized in ER and increased levels of CEs obtained from diet in skeletal muscle at age 5 months

• reduced level of total CEs versus free cholesterol in skeletal muscle at age 5 months

skeleton

kyphosis ( J:263681 )

• at age 6 months

growth/size/body

growth/size/body region phenotype ( J:263681 )

N	• weight at birth • daily food intake at age 5 months • heart weight at ages 5 months and 12 months

cachexia ( J:263681 , J:263681 )

	• from age 5 months (J:263681)
	• from age 2 months (J:263681)

Allelic Composition	Hprt1^{tm1(CAG-Gys1*)Jjg}/? Myl1^tm1(cre)Sjb/Myl1⁺
Genetic Background	involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hprt1^{tm1(CAG-Gys1*)Jjg} mutation (0 available); any Hprt1 mutation (1279 available)
Myl1^tm1(cre)Sjb mutation (2 available); any Myl1 mutation (17 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

homeostasis/metabolism

impaired exercise endurance ( J:244440 )

• in spite of increased skeletal muscle glycogen level, mice reach exhaustion earlier than wild-type controls in a treadmill endurance test

decreased aerobic running capacity ( J:244440 )

• mice cover a shorter distance than wild-type controls in a treadmill endurance test

increased skeletal muscle glycogen level ( J:244440 )

• under resting conditions, adult mice show a 7-fold increase in skeletal muscle glycogen level relative to wild-type controls

abnormal response to exercise ( J:244440 )

• at the point of exhaustion following treadmill exercise, mice show a greater reduction of glycogen content in skeletal muscle than wild-type controls

muscle

increased skeletal muscle glycogen level ( J:244440 )

• under resting conditions, adult mice show a 7-fold increase in skeletal muscle glycogen level relative to wild-type controls

behavior/neurological

impaired exercise endurance ( J:244440 )

• in spite of increased skeletal muscle glycogen level, mice reach exhaustion earlier than wild-type controls in a treadmill endurance test

decreased aerobic running capacity ( J:244440 )

• mice cover a shorter distance than wild-type controls in a treadmill endurance test

cellular

abnormal cellular respiration ( J:244440 )

• adult soleus muscle exhibits lower oxygen consumption affecting all mitochondrial states relative to wild-type muscle

Allelic Composition	Myl1^tm1(cre)Sjb/0 Ndufab1^tm1Xiwa/Ndufab1^tm1Xiwa
Genetic Background	involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Myl1^tm1(cre)Sjb mutation (2 available); any Myl1 mutation (17 available)
Ndufab1^tm1Xiwa mutation (0 available); any Ndufab1 mutation (8 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

homeostasis/metabolism

homeostasis/metabolism phenotype ( J:293657 )

N	• normal blood triglyceride, cholesterol and lactate levels

hypoglycemia ( J:293657 )

• 50% of normal level at age P3

decreased circulating insulin level ( J:293657 )

• 41% of normal level at age P3

decreased liver glycogen level ( J:293657 )

• at age P3

decreased skeletal muscle glycogen level ( J:293657 )

• at age P3

growth/size/body

decreased body size ( J:293657 )

• small body size at birth

postnatal growth retardation ( J:293657 )

muscle

muscle phenotype ( J:293657 )

N	• normal muscle morphology in newborns

decreased skeletal muscle glycogen level ( J:293657 )

• at age P3

liver/biliary system

decreased liver glycogen level ( J:293657 )

• at age P3

mortality/aging

preweaning lethality, complete penetrance ( J:293657 )

• early death within 5 postnatal days

cellular

disorganized mitochondrial cristae ( J:293657 )

• disrupted cristae and larger mitochondrial volumes devoid of cristae in skeletal muscle

Allelic Composition	Myl1^tm1(cre)Sjb/Myl1⁺ Shc1^tm4Paw/Shc1^tm9Paw
Genetic Background	involves: 129S1/Sv * 129X1/SvJ

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Myl1^tm1(cre)Sjb mutation (2 available); any Myl1 mutation (17 available)
Shc1^tm4Paw mutation (0 available); any Shc1 mutation (66 available)
Shc1^tm9Paw mutation (0 available); any Shc1 mutation (66 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

abnormal locomotor coordination ( J:122927 )

• motor abnormalities are less severe, similar to those observed in Shc1^tm4Paw homozygotes

ataxia ( J:122927 )

muscle

abnormal muscle spindle morphology ( J:122927 )

• between P22 and P35, intrafusal fiber numbers are reduced compared to controls

nervous system

abnormal muscle spindle morphology ( J:122927 )

• between P22 and P35, intrafusal fiber numbers are reduced compared to controls

Allelic Composition	Myl1^tm1(cre)Sjb/Myl1⁺ Shc1^tm7Paw/Shc1^tm9Paw
Genetic Background	involves: 129S1/Sv * 129X1/SvJ

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Myl1^tm1(cre)Sjb mutation (2 available); any Myl1 mutation (17 available)
Shc1^tm7Paw mutation (0 available); any Shc1 mutation (66 available)
Shc1^tm9Paw mutation (0 available); any Shc1 mutation (66 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

abnormal locomotor coordination ( J:122927 )

• motor abnormalities are similar to those observed in Shc1^tm7Paw homozygotes

ataxia ( J:122927 )

impaired limb coordination ( J:122927 )

muscle

decreased muscle spindle number ( J:122927 )

• between P22 and P35, muscle spindle and intrafusal fiber numbers are reduced compared to controls

nervous system

decreased muscle spindle number ( J:122927 )

• between P22 and P35, muscle spindle and intrafusal fiber numbers are reduced compared to controls

Allelic Composition	Myl1^tm1(cre)Sjb/Myl1⁺ Shc1^tm3Paw/Shc1^tm9Paw
Genetic Background	involves: 129S1/Sv * 129X1/SvJ

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Myl1^tm1(cre)Sjb mutation (2 available); any Myl1 mutation (17 available)
Shc1^tm3Paw mutation (0 available); any Shc1 mutation (66 available)
Shc1^tm9Paw mutation (0 available); any Shc1 mutation (66 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

abnormal locomotor coordination ( J:122927 )

• motor abnormalities are similar to those observed in Shc1^tm7Paw homozygotes

impaired limb coordination ( J:122927 )

nervous system

decreased muscle spindle number ( J:122927 )

• between P22 and P35, muscle spindle and intrafusal fiber numbers are reduced compared to controls

muscle

decreased muscle spindle number ( J:122927 )

• between P22 and P35, muscle spindle and intrafusal fiber numbers are reduced compared to controls

Allelic Composition	Myl1^tm1(cre)Sjb/Myl1⁺ Shc1^tm9Paw/Shc1^tm9Paw
Genetic Background	involves: 129S1/Sv * 129X1/SvJ

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Myl1^tm1(cre)Sjb mutation (2 available); any Myl1 mutation (17 available)
Shc1^tm9Paw mutation (0 available); any Shc1 mutation (66 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

abnormal locomotor coordination ( J:122927 )

• all viable mice are severely uncoordinated, appearing similar to Shc1^tm4Paw homozygotes

ataxia ( J:122927 )

impaired limb coordination ( J:122927 )

nervous system

decreased muscle spindle number ( J:122927 )

• between P22 and P35, muscle spindle numbers are reduced 50% compared to controls

• intrafusal fiber numbers are 59% that of controls

muscle

decreased muscle spindle number ( J:122927 )

• between P22 and P35, muscle spindle numbers are reduced 50% compared to controls

• intrafusal fiber numbers are 59% that of controls

Allelic Composition	Myl1^tm1(cre)Sjb/Myl1⁺ Tfam^tm1Lrsn/Tfam^tm1Lrsn
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Myl1^tm1(cre)Sjb mutation (2 available); any Myl1 mutation (17 available)
Tfam^tm1Lrsn mutation (1 available); any Tfam mutation (14 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

Skeletal muscle analysis of Tfam^tm1Lrsn/Tfam^tm1Lrsn Myl1^tm1(cre)Sjb/Myl1⁺ mice

mortality/aging

premature death ( J:81561 )

• death occurs at 4-5 months of age

muscle

increased skeletal muscle fiber size ( J:81561 )

• increased muscle fiber size containing enlarged mitochondria with distorted cristae

impaired skeletal muscle contractility ( J:81561 )

• shorter contraction times and shorter twitch-relaxation times

• decreased absolute muscle force

cellular

abnormal respiratory electron transport chain ( J:81561 )

• respiratory chain dysfunction in skeletal muscle

behavior/neurological

bradykinesia ( J:81561 )

• from 3-4 months of age

growth/size/body

weight loss ( J:81561 )

• beginning at 4-5 months of age

Allelic Composition	Trp53inp2^tm1Azo/Trp53inp2^tm1Azo Myl1^tm1(cre)Sjb/Myl1⁺
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Myl1^tm1(cre)Sjb mutation (2 available); any Myl1 mutation (17 available)
Trp53inp2^tm1Azo mutation (0 available); any Trp53inp2 mutation (10 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cellular

impaired autophagy ( J:212763 )

• mice show increased levels of LC3I and LC3II and mice treated with chloroquine to inhibit lysosomal protein degradation show a lower accumulatio of LC3II indicating reduced autophagy flux in muscle

• streptozotocin-treated mice show a blunted reduction in LC3I levels indicating reduced autophagy

growth/size/body

increased lean body mass ( J:212763 )

• increase in lean tissue volume

homeostasis/metabolism

homeostasis/metabolism phenotype ( J:212763 )

N	• 4 month old mice show no difference in glycemia and they respond normally in a glucose tolerance test

impaired autophagy ( J:212763 )

• streptozotocin-treated mice show a blunted reduction in LC3I levels indicating reduced autophagy

decreased physiological sensitivity to xenobiotic ( J:212763 )

• streptozotocin-treated mice show less muscle loss and a blunted reduction in LC3I levels indicating reduced autophagy

• however, mice show no differences from wild-type mice in the regeneration of cardiotoxin-induced muscle damage

muscle

abnormal skeletal muscle morphology ( J:212763 )

• mice show less muscle loss upon induction of diabetes with streptozotocin than wild-type mice indicating partial protection of muscle wasting induced by diabetes

increased skeletal muscle fiber diameter ( J:212763 )

• increase in cross-sectional area of muscle fibers, with an increase in area of type IIb, IIx, and IIa myofibers from tibialis anterior muscles

• however, no histological abnormalities or changes in fiber-type composition are seen and mitochondrial content and functionality are normal in myofibers

increased skeletal muscle weight ( J:212763 )

• mice show increased tibialis anterior, gastrocnemius, and quadriceps muscle weights

• however, no changes in body weight or food intake are seen

skeletal muscle hypertrophy ( J:212763 )

Allelic Composition	Myl1^tm1(cre)Sjb/Myl1⁺ Smarcd3^tm1Jddl/Smarcd3^tm1Jddl
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Myl1^tm1(cre)Sjb mutation (2 available); any Myl1 mutation (17 available)
Smarcd3^tm1Jddl mutation (1 available); any Smarcd3 mutation (25 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

homeostasis/metabolism

increased circulating glucose level ( J:256788 )

• mice exhibit elevated postprandial blood glucose after refeeding

• streptozotocin-treated mice have higher blood glucose levels than controls despite similarly low levels of plasma insulin

• high fat diet fed and streptozotocin-treated mice show an attenuated effect of the sufonylurea drug glibenclamide on blood glucose levels

impaired glucose tolerance ( J:256788 )

• glucose tolerance test indicates that high fat diet-fed mice are more glucose intolerant than controls

• streptozotocin-treated mice are more glucose-intolerant and develop more severe postprandial hyperglycemia following refeeding

• however, plasma insulin concentrations during glucose tolerance test are similar to controls

insulin resistance ( J:256788 )

• insulin tolerance test indicates that high fat diet-fed mice are more insulin resistant than controls

• streptozotocin-treated mice are more insulin-resistant

muscle

abnormal muscle physiology ( J:256788 )

• glucose-induced lactate production in plantaris, EDL, and soleus muscles cultured ex vivo is impaired

• however, muscle mass, endurance exercise capacity and muscle development are unaffected

growth/size/body

growth/size/body region phenotype ( J:256788 )

N	• chow-fed mice exhibit normal body weight and muscle mass

Allelic Composition	Ralgapa1^{tm2c(KOMP)Wtsi}/Ralgapa1^{tm2c(KOMP)Wtsi} Myl1^tm1(cre)Sjb/Myl1⁺
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Myl1^tm1(cre)Sjb mutation (2 available); any Myl1 mutation (17 available)
Ralgapa1^{tm2c(KOMP)Wtsi} mutation (0 available); any Ralgapa1 mutation (143 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

homeostasis/metabolism

increased circulating insulin level ( J:287672 )

• when fed a high-fat diet, but not standard chow

improved glucose tolerance ( J:287672 )

• when fed standard chow or a high-fat diet

abnormal lipid homeostasis ( J:287672 )

• mice fed olive oil exhibit improved ability to control blood lipids compared with control mice

increased circulating cholesterol level ( J:287672 )

• when fed standard chow or a high-fat diet

increased circulating free fatty acids level ( J:287672 )

• when fed a high-fat diet, but not standard chow

increased circulating triglyceride level ( J:287672 )

• when fed standard chow or a high-fat diet

muscle

increased muscle cell glucose uptake ( J:287672 )

• insulin-stimulated

cellular

increased muscle cell glucose uptake ( J:287672 )

• insulin-stimulated

Allelic Composition	Cox10^tm1Ctm/Cox10^tm1Ctm Myl1^tm1(cre)Sjb/Myl1⁺
Genetic Background	involves: 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cox10^tm1Ctm mutation (1 available); any Cox10 mutation (21 available)
Myl1^tm1(cre)Sjb mutation (2 available); any Myl1 mutation (17 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:101747 )

• mutant mice have a shorter life span

• females died younger than males

muscle

abnormal skeletal muscle morphology ( J:101747 )

• showed areas of mitochondrial proliferation and markedly enlarged and swollen mitochondria

• no signs of fibrosis, inflammation, or apoptosis were seen

increased variability of skeletal muscle fiber size ( J:101747 )

• mutant muscle fibers are more heterogeneous in size

decreased skeletal muscle mass ( J:101747 )

• at 3-4 months of age, severe reductions in muscle mass are seen

increased muscle fatigability ( J:101747 )

• maximal force evoked in mutant muscle is significantly smaller

• the muscles from mutant mice are more fatigable than control

myopathy ( J:101747 )

• mutant mice are healthy until approximately 3 months of age then develop a slowly progressive myopathy

• the myopathy starts earlier and worsens quicker in female

growth/size/body

weight loss ( J:101747 )

• at 3-4 months of age, they started to lose weight

• female mutant mice weigh less at an early age

skeleton

kyphosis ( J:101747 )

• starting at 3-4 months of age

behavior/neurological

decreased locomotor activity ( J:101747 )

• starting at 3-4 months of age

• in treadmill performance test, 2-month old mutant mice had difficulty in performing the task

• the female performance was significantly poorer than males

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
mitochondrial myopathy		DOID:699	OMIM:251900	J:101747

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 11/12/2024 MGI 6.24